Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Amneal Pharmaceuticals Inc (AMRX)
NASDAQ:AMRX
Amneal Pharmaceuticals (AMRX) Stock Price & Analysis
415 Followers
AMRX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.58 - $6.46
Previous Close$5.46
Volume1.22M
Average Volume (3M)1.50M
Market Cap
$1.68B
Enterprise Value$4.28B
Total Cash (Recent Filing)$91.54M
Total Debt (Recent Filing)$2.64B
Price to Earnings (P/E)-17.5
Beta1.35
Next Earnings
May 03, 2024EPS Estimate
$0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.31
Shares Outstanding307,006,908
10 Day Avg. Volume1,569,309
30 Day Avg. Volume1,502,079
Standard Deviation0.19
R-Squared0.14
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)-1.14
Price to Sales (P/S)0.70
Price to Cash Flow (P/CF)3.10
P/FCF Ratio3.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.79
Enterprise Value/Gross Profit5.21
Enterprise Value/Ebitda21.18
Forecast
1Y Price Target
$7.42Price Target Upside35.90% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Amneal Pharmaceuticals News
Ownership Overview
55.54% Insiders
8.18% Mutual Funds
7.37% Other Institutional Investors
28.90% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AMRX FAQ
What was Amneal Pharmaceuticals Inc’s price range in the past 12 months?
Amneal Pharmaceuticals Inc lowest stock price was $1.57 and its highest was $6.46 in the past 12 months.
What is Amneal Pharmaceuticals Inc’s market cap?
Currently, no data Available
When is Amneal Pharmaceuticals Inc’s upcoming earnings report date?
Amneal Pharmaceuticals Inc’s upcoming earnings report date is May 03, 2024 which is in 15 days.
How were Amneal Pharmaceuticals Inc’s earnings last quarter?
Amneal Pharmaceuticals Inc released its earnings results on Mar 01, 2024. The company reported $0.14 earnings per share for the quarter, beating the consensus estimate of $0.09 by $0.05.
Is Amneal Pharmaceuticals Inc overvalued?
According to Wall Street analysts Amneal Pharmaceuticals Inc’s price is currently Undervalued.
Does Amneal Pharmaceuticals Inc pay dividends?
Amneal Pharmaceuticals Inc does not currently pay dividends.
What is Amneal Pharmaceuticals Inc’s EPS estimate?
Amneal Pharmaceuticals Inc’s EPS estimate is $0.09.
How many shares outstanding does Amneal Pharmaceuticals Inc have?
Amneal Pharmaceuticals Inc has 308,554,230 shares outstanding.
What happened to Amneal Pharmaceuticals Inc’s price movement after its last earnings report?
Amneal Pharmaceuticals Inc reported an EPS of $0.14 in its last earnings report, beating expectations of $0.09. Following the earnings report the stock price went down -0.906%.
Which hedge fund is a major shareholder of Amneal Pharmaceuticals Inc?
Among the largest hedge funds holding Amneal Pharmaceuticals Inc’s share is Caxton Associates LP. It holds Amneal Pharmaceuticals Inc’s shares valued at 506K.
---
Amneal Pharmaceuticals Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$7.42 (35.90% Upside)
$7.42 (35.90% Upside)
Blogger Sentiment
Bullish
AMRX Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 13.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 5.5%
Last 30 Days ▼ 5.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
230.90%
12-Months-Change
Fundamentals
Return on Equity
-52.79%
Trailing 12-Months
Asset Growth
-8.60%
Trailing 12-Months
Company Description
Amneal Pharmaceuticals Inc
Amneal Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generics and Specialty segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ.
---
AMRX Company Deck
---
AMRX Earnings Call
Q4 2024
0:00 / 0:00
---
AMRX Stock 12 Months Forecast
Average Price Target
$7.42
▲(35.90% Upside)
Technical Analysis
Best Analysts Covering AMRX
1 Year
1 Year Success Rate
5/11 ratings generated profit
1 Year Average Return
+43.13%
assigned a buy rating 2 months ago
Copying Balaji Prasad's trades and holding each position for 1 Year would result in 45.45% of your transactions generating a profit, with an average return of +43.13% per trade.
---